Innovators Program Offers Free Antibodies for Sharing Data
News Nov 17, 2010
The program encourages researchers to share their data generated using Thermo Scientific Pierce Antibodies with the rest of the scientific community in exchange for free antibodies.
"Our Innovators Program rewards customers for sharing their data and feedback on qualified antibodies,” said Carrie Clothier, product manager for the Pierce® Antibodies product line. "This is the most aggressive program of its kind in the industry and illustrates our commitment to antibody quality."
To participate in the Pierce Innovators Program, researchers should submit their data using Pierce qualified antibodies, plus all necessary controls. Data will be accepted for any of the following antibody applications: Western blotting, immunohistochemistry (IHC), immunocytochemistry (ICC), immunofluorescence (IF), fluorescence-activated cell sorting (FACS), enzyme-linked immunosorbant assay (ELISA), immunoprecipitation (IP) and chromatin immunoprecipitation (ChIP).
To review details on the submission process, the rewards and the official program rules, please visit www.thermoscientific.com/innovatorsprogram
Study Reveals How MRSA Infection Compromises Lymphatic FunctionNews
Infections of the skin or other soft tissues with the hard-to-treat MRSA bacteria appear to permanently compromise the lymphatic system, which is crucial to immune system function. Investigators describe how MRSA infection impairs the ability of lymphatic vessels to pump lymphatic fluid to lymph nodes in mouse models, which may contribute to the frequent recurrences of MRSA infection experienced by patients.
Possible Biomarker to Identify Who Would Benefit from ImmunotherapyNews
While immunotherapy has made a big impact on cancer treatment, the fact remains that only about a quarter of patients respond to these treatments. In a new study, researchers examined tissue samples from melanoma and ovarian cancer patients treated with immunotherapies and found a link between the percentage of antigen-presenting cells expressing PD-L1 and an objective clinical response to treatment.READ MORE
Fight Against Cancer: Drug Combination Helps Kickstart the Immune SystemNews
Scientists from King's College London have found a way to boost the immune system to help it fight back against cancer.
The breakthrough involves the first ever use of a combination of chemotherapy and a drug being trialled as a treatment for neonatal jaundice, that together help kick start the body's natural defences.